ONCOVITA, a biotechnology company specializing in innovative vaccine development and a spin-off from the Institut Pasteur, and UNITHER Pharmaceuticals, a global leader in sterile unit-dose manufacturing, have formed a...

View the Online Magazine

Launches

Roche launches new innovation center in Boston

The Roche Genentech Innovation Center Boston has launched at Harvard’s Enterprise Research Campus in Allston, strengthening a long-standing partnership in areas such as disease...

Ultra-Hygienic mixing at small-scale

Introducing the new 150 UHS Ultra-Hygienic Small-Scale In-Line mixer from Silverson Machines. The 150 UHS In-Line is designed for Ultra Hygienic applications typically encountered in...

Pioneer Group drives AI innovation in healthcare through industry and academic collaboration

Pioneer Group, the life science infrastructure and venture building specialist, has joined forces with Innovate UK, The Medical Research Council (MRC) and AstraZeneca, to...

Suppliers Guide

Check out our Suppliers Guide or contact our team and get your company listed

Subscribe

Keep up with what's happening in the industry and subscribe to our weekly newsletter

Events

Get your event seen by potential candidates on the world's leading industry site.

Supply Chain

NeoGenomics expands oncology testing reach with acquisition of Pathline

NeoGenomics, a provider of oncology testing services, has acquired Pathline, a CLIA/CAP/NYS-certified laboratory based in New Jersey. The acquisition strengthens NeoGenomics’ commercial presence in the...

Pharmanovia signs exclusive distribution agreement with Er-Kim for Sunosi in Eastern Europe

Pharmanovia has signed an exclusive distribution agreement with Er-Kim, to enhance the availability of Sunosi (Solriamfetol), a first-in-class treatment for Excessive Daytime Sleepiness (EDS),...

Dr. Reddy’s enters into collaboration with Henlius for commercialization of HLX15, a biosimilar candidate to Darzalex & Darzalex Faspro in the U.S. and Europe

Dr. Reddy’s Laboratories has entered into a license agreement with Shanghai Henlius Biotech for the commercialization of HLX15, Henlius’ investigational daratumumab biosimilar candidate to...

Er-Kim signs distribution agreement with the MEDICE Health Family for Vafseo in Central & Eastern Europe

Er-Kim, an international company specializing in the commercialization of novel therapies for pharmaceutical and biopharmaceutical companies, has signed a distribution agreement with the MEDICE...

Approvals

Manufacturiung

Finance

Research & Development
Latest

ONCOVITA and UNITHER Pharmaceuticals to develop new prophylactic vaccine based on Measovir and Euroject technologies

ONCOVITA, a biotechnology company specializing in innovative vaccine development and a spin-off from the Institut Pasteur, and UNITHER Pharmaceuticals, a global leader in sterile...

Roche to collaborate with Zealand Pharma to co-develop and co-commercialise petrelintide for obesity

Roche has entered into an exclusive collaboration and licensing agreement with Zealand Pharma to co-develop and co-commercialise petrelintide, Zealand Pharma’s amylin analog as a...

Orion to open new Biologics R&D Centre in Cambridge

Orion Corporation is establishing a new research & development centre in Cambridge, UK during 2025 to accelerate its global growth strategy and the development...

Magnet Biomedicine and Lilly to develop novel molecular glue medicines

Magnet Biomedicine, a biopharmaceutical company advancing molecular glue discovery with rational selection and design, has entered a collaboration and license agreement with Eli Lilly...

Bioxodes secures Orphan Drug Designation for hemorrhagic stroke therapeutic candidate in US and Europe

Bioxodes, a clinical stage biopharmaceutical company developing novel therapies for the prevention and treatment of thrombotic and inflammatory diseases, has received Orphan Drug Designation...

Appointments